<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04287595</url>
  </required_header>
  <id_info>
    <org_study_id>2</org_study_id>
    <nct_id>NCT04287595</nct_id>
  </id_info>
  <brief_title>Effect of Orange Aroma on Nausea, Vomiting and Anxiety During Autologous Stem Cell Transplantation</brief_title>
  <official_title>Inhalation Aromatherapy on Nausea, Vomiting and Anxiety During Autologous Hematopoietic Stem Cell Transplantation: An Open-label Randmized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hacettepe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hacettepe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing stem cell transplantation for the first time will be entered.&#xD;
      Participants will be randomized to one of two study arms: Arm 1: intervention (routine care+&#xD;
      inhalation aromatherapy); Arm 2: Control (Routine care) Hypotheses: (1) Patients receiving&#xD;
      inhalation aromatherapy will experience less severe nausea and less frequent vomiting&#xD;
      episodes than those receiving only routine care; and (2) patients receiving inhalation&#xD;
      aromatherapy will demonstrate lower anxiety levels just after AHSCT than those receiving only&#xD;
      routine care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Earlier research indicates that aromatherapy is promising to relieve in DMSO related nausea&#xD;
      and anxiety in autologous stem cell transplant patients. The current study seeks to confirm&#xD;
      and extend these findings in a 2-arm, open-label randomized, controlled study of 70 cancer&#xD;
      patients undergoing autologous stem cell transplantation. All patients will receive a&#xD;
      standardized premedication. Arm 1: Intervention (inhalation aromatherapy with orange&#xD;
      essential oil during stem cell infusion); Arm 2: Control (routine care). The researchers&#xD;
      hypothesize that inhalation aromatherapy with orange essential oil will be effective in&#xD;
      reducing DMSO related nausea and vomiting and demonstrate lower anxiety levels just after&#xD;
      autologous stem cell transplantation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 28, 2015</start_date>
  <completion_date type="Actual">January 13, 2017</completion_date>
  <primary_completion_date type="Actual">January 13, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in nausea severity</measure>
    <time_frame>At 1st minute of each stem cell infusion bag</time_frame>
    <description>Patient report Nausea severity will be assessed based on patient report by using a visual analog scale. The patients will be asked to rate their nausea severity and place a mark on the scale from 0 to 10.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in number of vomiting</measure>
    <time_frame>From 1st minute of the stem cell infusion to completion of the intervention</time_frame>
    <description>Observation Number of vomiting and retching episodes will be observed by the researcher who apply aromatherapy and recorded in a vomiting and retching episodes form.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>anxiety</measure>
    <time_frame>Through stem cell infusion completion, an avarege of 30 minutes</time_frame>
    <description>Patient report State Anxiety Inventory will be used to measure anxiety level.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Nausea</condition>
  <condition>Vomiting</condition>
  <condition>Anxiety State</condition>
  <arm_group>
    <arm_group_label>intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>inhalation aromatherapy with orange essential oil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>routine care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inhalation aromatherapy with orange essential oil</intervention_name>
    <arm_group_label>intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age &gt; 18 years,&#xD;
&#xD;
          -  the absence of any mental conditions including depression, anxiety disorders,&#xD;
             psychotic disorders or dementia that may affect the patients' communication abilities&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with chronic obstructive pulmonary disease or asthma,&#xD;
&#xD;
          -  a history of allergy to orange or orange essential oil,&#xD;
&#xD;
          -  presence of persistent nausea and vomiting due to conditioning regimens,&#xD;
&#xD;
          -  receiving antiemetic other than routine premedication,&#xD;
&#xD;
          -  patients undergoing AHSCT for the second or more time were excluded&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nur Izgu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 22, 2020</study_first_submitted>
  <study_first_submitted_qc>February 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2020</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hacettepe University</investigator_affiliation>
    <investigator_full_name>Nur Izgu</investigator_full_name>
    <investigator_title>Assoc. Prof., RN, PhD</investigator_title>
  </responsible_party>
  <keyword>anxiety</keyword>
  <keyword>hematopoietic stem cell transplantation</keyword>
  <keyword>inhalation aromatherapy</keyword>
  <keyword>nausea</keyword>
  <keyword>randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

